Deep Flaws in FDA Oversight of Medical Devices, and Patient Harm, Exposed in Lawsuits and Records
Thousands of medical devices are sold, and even implanted, with no safety tests.
The independent source for health policy research, polling, and news.
61 - 80 of 111 Results
Thousands of medical devices are sold, and even implanted, with no safety tests.
Obamacare had its moment, but not until the faceoff’s final minutes. Front-runner Donald Trump again was not on the debate stage, leaving the other Republican presidential hopefuls to slug it out to break through and gain voters’ attention.
At least 17 states have issued PFAS-related fish consumption advisories, Ñî¹óåú´«Ã½Ò•îl Health News found. But with no federal guidance, what is considered safe to eat varies significantly among states, most of which provide no regulation.
More than 16 million Americans who buy their own health insurance through state and federal marketplaces have until Jan. 15 to compare prices, change their coverage, or enroll for the first time.
The number of men in the state taking paid family leave to bond with a new child has risen nearly 20% since the start of the pandemic.
Narcan is available without a prescription. Addiction treatment experts hope this move will increase access to the medication, which can reverse opioid overdoses. But hurdles remain: cost and stigma.
The federal government is proposing having Medicare pay professionals to train family caregivers how to perform tasks like bathing and dressing their loved ones, and properly use medical equipment.
California’s health insurance exchange will reduce how much some patients pay for care next year, including hospital deductibles, appointment copays, and prescription drugs. Lawmakers pressed Gov. Gavin Newsom to make good on a four-year-old pledge to use proceeds from a tax penalty on uninsured people to help people pay for treatment.
Congress has until October to avert cuts to a Medicaid program intended to support safety-net hospitals that, in practice, improves the bottom lines of other hospitals, too. Hospital leaders say now is not a good time for the cuts — which lawmakers have so far postponed 13 times.
As settlement dollars land at the state level, state councils wield significant power in determining how the windfall gets spent. And, though they will likely include the most knowledgeable voices on addiction, these panels also face concerns about conflicts of interest and other issues.
As marijuana has become far more mainstream, potent, and sometimes dangerous, uneven regulation at the state and federal levels leaves consumers at risk.
As your circle of close friends shrinks, there are ways to rebuild — but not replace — the social network you had when you were younger.
The pandemic gave federal officials expanded power to access crucial data about the spread of covid-19, but that authority will change when the public health emergency sunsets in May. That, along with the end of popular covid trackers, will make it harder for policymakers and the public to keep an eye on covid and other threats.
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
A growing number of states — including Maryland, Colorado, and Massachusetts — are using tax forms to point people toward lower-cost health coverage available through state insurance marketplaces.
Colorado’s proposed legislation to cap the copay for the EpiPen is part of a nationwide trend as more states try to shield patients from skyrocketing drug prices.
Washington state regulators found formaldehyde, lead, and arsenic in lipstick, powder foundations, skin lotions, and hair products marketed to and popular with women of color. Now legislators there are seeking to ban the products and, like at least a dozen other states, make up for lax federal rules.
Abortion is a top issue for state lawmakers meeting for their first full sessions since Roe v. Wade was overturned.
Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for patients to access.
New U.S. Census Bureau data shows a large segment of Californians are working from home for part or all of the week. Researchers say the shift will ripple through the broader economy in ways big and small.
© 2026 KFF